ChartMill · Oct 26, 2026
US Session Top Movers: CLRO and XXII Lead Stock Gainers and Losers
US session top movers: CLRO gained 54.77% and XXII fell 54.27%, leading individual stock gainers and losers with longer-term performance included.
LU
NASDAQ · LUCD
Lucid Diagnostics Inc. Common Stock
Healthcare · Medical - Devices
$0.43
Up+$0.02 (+5.03%)
Updated Oct 30, 2026, 5:56 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 117.03M
- P/E ratio
- -2.06
- Dividend yield
- 0.00%
- 52-week range
- $0.30 – $1.63
- Volume
- 5.06M
- Avg. volume
- 939.24K
Price performance · LUCD
LUCD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
LUCD closed at $0.43 after 21 trading sessions, down 31.90% for the selected period.
- Last close
- $0.43
- Period change
- -31.90%
- Period low
- $0.33
- Period high
- $0.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $0.4116 | $0.4563 | $0.403 | $0.4323 | 5.06M |
| Oct 28, 2026 | $0.4376 | $0.44 | $0.38 | $0.4116 | 6.33M |
| Oct 27, 2026 | $0.52 | $0.5456 | $0.415 | $0.4381 | 10.24M |
| Oct 26, 2026 | $0.416 | $0.56 | $0.4059 | $0.5007 | 43.58M |
| Oct 23, 2026 | $0.4341 | $0.4525 | $0.388 | $0.411 | 111.8M |
| Oct 22, 2026 | $0.321 | $0.33 | $0.303 | $0.3277 | 48.1M |
| Oct 21, 2026 | $0.36 | $0.3925 | $0.3209 | $0.3334 | 3.69M |
| Oct 20, 2026 | $0.3683 | $0.3748 | $0.3033 | $0.3519 | 6.33M |
| Oct 19, 2026 | $0.4802 | $0.4802 | $0.3583 | $0.3774 | 4.27M |
| Oct 16, 2026 | $0.5224 | $0.5255 | $0.4702 | $0.478 | 2.34M |
| Oct 15, 2026 | $0.5442 | $0.5687 | $0.51 | $0.5201 | 3.01M |
| Oct 14, 2026 | $0.591 | $0.6177 | $0.5401 | $0.5431 | 1.82M |
| Oct 13, 2026 | $0.60 | $0.6198 | $0.5768 | $0.606 | 1.1M |
| Oct 12, 2026 | $0.6315 | $0.66 | $0.5974 | $0.5974 | 1.64M |
| Oct 9, 2026 | $0.65 | $0.6897 | $0.6205 | $0.638 | 1.95M |
| Oct 8, 2026 | $0.61 | $0.6743 | $0.6034 | $0.6501 | 2.51M |
| Oct 7, 2026 | $0.591 | $0.653 | $0.5875 | $0.6235 | 1.71M |
| Oct 6, 2026 | $0.60 | $0.6107 | $0.58 | $0.60 | 1.46M |
| Oct 5, 2026 | $0.6231 | $0.6764 | $0.59 | $0.5933 | 1.83M |
| Oct 2, 2026 | $0.6348 | $0.6753 | $0.6251 | $0.6273 | 2.26M |
| Oct 1, 2026 | $0.7232 | $0.7253 | $0.50 | $0.6348 | 6.79M |
Latest LUCD news
The latest Smart Investors Daily articles mentioning LUCD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LUCD research
Overview
Company profile and research snapshot.
Company profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 23, 2026 | BTIG | Buy | — |
| Aug 27, 2026 | Ascendiant Capital | Buy | — |
| Aug 17, 2026 | BTIG | Buy | — |
| Jun 8, 2026 | Ascendiant Capital | Buy | — |
| May 15, 2026 | Maxim Group | Buy | — |
News briefing
Generated Oct 29, 2026, 9:24 PM
Why Is LUCD Up Today?
Lucid Diagnostics Inc. Common Stock (LUCD) gained 5.03% in Tuesday's pre-market session, rising $0.02 as the healthcare sector showed broad movement across multiple names. While limited specific catalyst information is available, the stock's participation in a broader healthcare market shift suggests moderate investor interest in the diagnostic space.
Bottom line: LUCD's 5.03% pre-market gain appears driven by broader healthcare sector activity rather than company-specific news, suggesting cautious optimism but limited fundamental support for the current move. Investors should await more substantial catalysts or confirmation of sector trends during regular trading to validate whether today's strength represents a genuine shift in investor sentiment or a temporary momentum play.
ChartMill · Oct 26, 2026
Unusual Volume in Small-Cap US Stocks: Mixed Session of Gains and Sharp Losses
Unusual volume in US small-cap stocks: RBNE, SHFS, AARD, XXII and others traded well above 50-day averages, with sharp losses and double-digit gains.
Benzinga · Oct 26, 2026
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Surgery Partners (NASDAQ:SGRY) shares moved upwards by 46.9% to $23.14 during Monday's regular session. The market value of their outstanding shares is at $2.0 billion. SciSparc (NASDAQ:SPRC) shares rose
ChartMill · Oct 23, 2026
Most Active US Stocks: Oct. 23, 2026 Volume Leaders
GPUS, XXII, SHFS, LUCD and RIME led US share turnover on Oct. 23, 2026, with volume spikes and price moves ranging from sharp gains to steep declines.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
